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Abstract
Background
In many parts of sub-Saharan Africa, urogenital and intestinal schistosomiasis co-occur,
and mixed species infections containing both Schistosoma haematobium and S.mansoni
can be common. During co-infection, interactions between these two species are possible,
yet the extent to which such interactions influence disease dynamics or the outcome of con-
trol efforts remains poorly understood.
Methodology/Principal Findings
Here we analyse epidemiological data from three West African countries co-endemic for
urogenital and intestinal schistosomiasis (Senegal, Niger and Mali) to test whether the
impact of praziquantel (PZQ) treatment, subsequent levels of re-infection or long-term infec-
tion dynamics are altered by co-infection. In all countries, positive associations between the
two species prevailed at baseline: infection by one species tended to predict infection inten-
sity for the other, with the strength of association varying across sites. Encouragingly, we
found little evidence that co-infection influenced PZQ efficacy: species-specific egg reduc-
tion rates (ERR) and cure rates (CR) did not differ significantly with co-infection, and varia-
tion in treatment success was largely geographical. In Senegal, despite positive
associations at baseline, children with S.mansoni co-infection at the time of treatment were
less intensely re-infected by S. haematobium than those with single infections, suggesting
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competition between the species may occur post-treatment. Furthermore, the proportion of
schistosome infections attributable to S.mansoni increased over time in all three countries
examined.
Conclusions/Significance
These findings suggest that while co-infection between urinary and intestinal schistosomes
may not directly affect PZQ treatment efficacy, competitive interspecific interactions may
influence epidemiological patterns of re-infection post-treatment. While re-infection patterns
differed most strongly according to geographic location, interspecific interactions also seem
to play a role, and could cause the community composition in mixed species settings to shift
as disease control efforts intensify, a situation with implications for future disease manage-
ment in this multi-species system.
Author Summary
In many parts of Africa both urinary and intestinal schistosomiasis are endemic, and
mixed species infections can be common. However, little is known about potential within-
host interactions between the causative parasites, S. haematobium and S.mansoni, and
how these might influence treatment success and post-treatment patterns of re-infection.
Here, we bring together datasets from three West African countries to examine the epide-
miological evidence for interactions between these two schistosome species relevant to the
impact of treatment programmes using praziquantel (PZQ). Encouragingly, PZQ efficacy
(in a double 40mg/kg dose format) was not significantly altered by co-infection, though
since co-infections tended to be heavier, complete clearance was less likely than for single
species infections. Despite positive associations in infection intensity for these two species
at baseline, Senegalese children that were successfully treated for S. haematobium showed
less intense re-infection if they were co-infected with S.mansoni at the point of treatment.
Furthermore, in all three settings, the proportion of infections attributable to S.mansoni
increased over successive rounds of PZQ treatment. These data suggest asymmetric com-
petition may occur between S. haematobium and S.mansoni in the context of drug treat-
ment, which may alter schistosome species composition as PZQ-based control
programmes proceed.
Introduction
Globally, at least 230 million people are estimated to have schistosomiasis [1]. In sub-Saharan
Africa where the disease burden is highest, Schistosoma haematobium and S.mansoni, causing
urogenital and intestinal schistosomiasis respectively, frequently overlap in their geographic distri-
bution [2–5] as do their respective snail hosts Bulinus and Biompharia spp. In such areas, mixed
species infections can be common [6–10], and may be even more widespread than currently rec-
ognised if diagnostic methods with greater sensitivity than standard microscopy are applied [11].
Co-infection with both S. haematobium and S.mansoni generates the potential for within-
host parasite interactions, whereby the presence of one species may alter the course of infection
or disease caused by the other. Such interactions could arise through competition for nutrients
or mates, or immune-mediated mechanisms, including cross-reactive immune responses.
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Immune-mediated interactions may also arise through or be affected by drug treatment, if spe-
cies differ in drug susceptibility, or if the drug in question alters host immunity in a way that
favours one species over another [12, 13]. Although rarely investigated, such interspecific inter-
actions may have important implications for schistosomiasis epidemiology, associated morbid-
ity, and the effectiveness of control measures including PZQ treatment, the cornerstone of
current schistosomiasis control programmes [14].
Evidence for biologically relevant interactions between co-infecting S. haematobium and S.
mansoni comes from studies in animal models as well as humans. These two species can engage
in mate competition, since during co-infection, infertile interspecific mating pairs form result-
ing in the release of ectopic eggs: S. haematobium eggs in faeces or S.mansoni eggs in urine [7,
15–17]. Moreover, mixed species infections produce different morbidity profiles in humans,
altering the relative levels of bladder and liver morbidity [6, 8, 15, 18, 19]. Immune-mediated
competition between S. haematobium and S.mansoni has also been reported in animal models
[20–22] and immunological studies suggest widespread cross-reactivity among antigenic epi-
topes from different schistosome species [23].
However, exactly how such interactions might play out in epidemiological settings, and in
the context of mass PZQ treatment, remains underexplored. In parts of Africa the species com-
position of schistosomiasis infections has shifted notably over time. At sites in Senegal, Niger,
Cameroon and Egypt, S.mansoni has been introduced through changes in irrigation (e.g. dam
construction), and has been seen to increase in prevalence and subsequently ‘take over’ from S.
haematobium 24–29]. While changes in the distribution and relative abundance of Biompha-
laria and Bulinus snails following water resource development have undoubtedly played a key
role in such shifts [25, 28, 30, 31], whether and how within-host interactions between S. haema-
tobium and S.mansonimight influence schistosomiasis epidemiology remains to be fully inves-
tigated. PZQ treatment could also alter the relative abundance of these two species, if drug
efficacy varies between species or during co-infection, or if treatment alters interspecific inter-
actions during re-infection [14]. With increasing momentum behind scaling up schistosomia-
sis control programmes across much of Africa [32], there is a clear need to understand how
each species responds to treatment, whether these responses depend on the parasite commu-
nity context, and the implications for epidemiology and morbidity.
Here, we use three epidemiological datasets from co-endemic areas of West Africa (Senegal,
Niger and Mali) to investigate potential interactions between S. haematobium and S.mansoni
in the context of PZQ treatment. In particular, we examine whether PZQ efficacy is altered by
co-infection, the impact of co-infection on individual re-infection post-treatment, and how
schistosome species composition, as well as prevalence and mean intensity of infection changes
over the course of successive treatment rounds at the population level.
Methods
Study sites and datasets
Two of the datasets analysed here come from co-endemic villages in Niger [4] and Senegal [5]
collected as part of the CONTRAST project, while the third comes from sentinel sites moni-
tored as part of Mali’s schistosomiasis control programme monitoring and evaluation activities
[6]. These datasets are described in more detail below, their characteristics are summarised in
Table 1, and their locations are shown in Fig 1.
Senegal. Data were collected in 2007–8 from two villages (Nder and Temeye) in the Sene-
gal River Basin (Fig 1). In previous work [5], village-level variation in PZQ efficacy and re-
infection dynamics was documented over a one-year period at these sites. Here, we extend
analysis of these data to consider the influence of individual co-infection status on PZQ
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efficacy, parasite clearance and re-infection dynamics. Full details on these sites and study
design are given in [5], but a brief description of the study design follows. At baseline, children
aged 5 to 15 were recruited in each village, given a unique identification number, and asked to
provide a single urine and stool sample on three consecutive mornings. S. haematobium egg
counts were made from filtrations of 10 ml of urine using the standard urine filtration method,
and duplicate Kato-Katz thick smears were examined from each stool sample in order to
Table 1. Characteristics of study sites in Senegal, Niger and Mali used in this study.
Country Study type Site/s N
children
Baseline
uninfected
(%)
Baseline single S.
haematobium (%)
Baseline
single S.
mansoni (%)
Baseline co-
infected (%)
Senegal PZQ efﬁcacy Temeye 89 0 21.3 19.1 59.6
Nder 107 0 0 2.8 97.2
Niger PZQ efﬁcacy Diambala 180 0 22.2 24.4 53.3
Namarigoungou 223 0 13.5 40.4 46.2
Mali Monitoring &
evaluation of national
treatment programme
29 co-endemic schools in three
regions (Bamako, Koulikoro and
Ségou), 20 of which followed annually
for 3 years.
2477 28.5 45 5.5 21
doi:10.1371/journal.pntd.0004019.t001
Fig 1. Map of the study sites in Senegal, Niger and Mali.
doi:10.1371/journal.pntd.0004019.g001
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calculate the number of S.mansoni eggs per gram of stool. Only children infected with either S.
haematobium, S.mansoni, or both species were recruited into the follow-up study if consent-
ing, and all infected children were then treated with two 40mg/kg doses of PZQ, spaced 3
weeks apart. Follow-up surveys were conducted at 6 weeks after baseline/the first PZQ dose (to
monitor PZQ efficacy), 6 months from baseline and 12 months from baseline. All children
were screened for both S. haematobium and S.mansoni at each time point, using the same
diagnostics used at baseline. No treatment was given at the 6 week follow-up, but all children
were given two 40mg/kg PZQ doses 3 weeks apart at both the 6 and 12 month follow ups. For
S. haematobium, the number of eggs per 10ml urine was calculated for each sample, and infec-
tion intensity taken as the mean of these values across all available samples from a 3-day sam-
pling period. For S.mansoni, infection intensity was taken as the mean number of eggs per
gram of stool across all samples from the 3-day sampling period.
Niger. Data were collected in 2007–8 from two S. haematobium/S.mansoni co-endemic
villages situated in the western part of the country along the Niger River—Diambala and
Namarigoungou. The study design was very similar to the Senegal study described above, and
is described fully in [4]. Briefly, children aged 6 to 15 infected with either S. haematobium or S.
mansoni were recruited into the study at baseline, given unique identifiers, and follow-up sur-
veys were conducted at 6 weeks, 6 months and 12 months from baseline. As in Senegal, two
40mg/kg doses of PZQ were given to all infected children after recruitment, and to all children
in the study at the 12-month sampling point, irrespective of infection status. However, unlike
in Senegal, no treatment was given 6 months from baseline. At each survey time-point, all chil-
dren were screened for both S. haematobium and S.mansoni using the same diagnostic tech-
niques used in the Senegal study, with the exception that one Kato-Katz slide was read per
stool sample rather than two.
Mali. The Malian data analysed here formed part of the Monitoring and Evaluation com-
ponent of the Mali National Schistosomiasis Control Program, supported by the Schistosomia-
sis Control Initiative (SCI). In 2004, a set of 33 schools (sentinel sites) were randomly selected
from all schools in three regions known a priori to be highly endemic for schistosomiasis:
Bamako, Ségou, and Koulikoro. Only the 29 schools that were co-endemic for S. haematobium
and S.mansoni at baseline are included in the analyses presented here, as our focus is on indi-
vidual level determinants of infection traits, rather than site to site variation in co-endemicity.
Baseline data were collected in 2004. At each school, 50–110 children (approximately equal
numbers of boys and girls) aged 7 to 14 years old were recruited, irrespective of infection status.
Participants were asked to provide a single stool sample, and two urine samples on two conse-
cutive days. Urine filtration and Kato-Katz examinations were carried out as described in [33],
and infection intensity was calculated as the arithmetic mean number of S. haematobium eggs
per 10ml urine, or mean number of S.mansoni eggs per gram of stool. Two subsequent follow-
up surveys were conducted on this cohort in 2005 and 2006, immediately prior to annual PZQ
administration by the national control programme.
Statistical analyses
All statistical analyses were performed in R v3.1.1. Descriptive statistics (prevalence, mean
infection intensity and confidence intervals) were calculated using the survey package [34],
accounting for clustering of the data by school or village where necessary. The significance of
model terms was assessed using likelihood ratio tests, which compared full models to models
excluding the term of interest.
Baseline associations between S. haematobium and S.mansoni. First, we tested whether
the likelihood of infection by each schistosome species depended on co-infection with the other,
Epidemiology of Schistosome Interactions
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using baseline data fromMali where children were recruited irrespective of infection status.
Binomial generalized linear mixed models (GLMMs) with a logit link were performed using the
glmer function in package lme4, with either S. haematobium or S.mansoni infection status as
the response, and school fitted as a random intercept term. All children at the 29 co-endemic
Malian schools surveyed at baseline were included. Co-infection status was coded according to
WHO infection intensity categories: for S. haematobium, uninfected, light (<50 eggs/10ml
urine) or heavy (50eggs/10ml urine) infection, and for S.mansoni, uninfected, light (1–99
epg), moderate (100–399 epg), or heavy (400 epg) infection. Linear and quadratic terms for
age (mean-centred) were included as covariates, as well as gender and geographic region (as a
3-level factor). An interaction term between region and co-infection status was also examined to
test for geographic heterogeneity in schistosome species associations. For all countries we also
assessed whether baseline infection intensity was associated with co-infection, by modelling log-
transformed egg counts for a given species as a function of co-infection status, age, gender and
location (as a 2-level factor for village in both Senegal and Niger, and a 3-level factor for region
in Mali). These infection intensity analyses included infected children only.
PZQ efficacy and parasitological cure. Data on the immediate effect of PZQ (6 weeks
after the first of two 3-week spaced treatments) were available for four villages in Senegal and
Niger. To examine whether co-infection might influence PZQ efficacy, for each country we cal-
culated the egg reduction rate (ERR) for each schistosome species, in single and co-infected
individuals respectively. ERR was calculated using the formula recommended in WHO guide-
lines [35], as the difference between the (arithmetic) mean pre- and post-intervention egg
counts divided by the mean pre-intervention egg count, multiplied by 100. The calculation
included only individuals infected with the focal species at baseline, with known baseline co-
infection status, and for which an egg count at 6 weeks post-treatment was available. Although
a wide range of formulas has been used in the past to calculate ERR, this formula was used as it
has been shown to be the most robust metric for evaluating drug efficacy [36, 37]. Permutation
tests were used to examine whether ERR differed significantly (p<0.05) according to co-infec-
tion status. We also calculated species-specific cure rates (CR)—the proportion of infected
individuals that cleared infection six weeks after the first PZQ dose, by country and co-infec-
tion status. With the exception of S. haematobium in Niger (for which parasitological cure was
almost universal) we modelled factors affecting individual parasite clearance 6 weeks after PZQ
using binomial GLMs. Alongside co-infection status as the key predictor of interest, a number
of covariates were controlled for in these models, including initial infection intensity of the
focal species (as logged epg or eggs/10ml urine) to control for differences in efficacy arising
from varying infection intensity and village.
Longitudinal dynamics and re-infection. Using the Mali dataset, we examined whether
individuals’ probability of infection changed across annual rounds of PZQ treatment, accord-
ing to their initial co-infection status. These analyses involved a subset of 20 schools from the
original 29 co-endemic sentinel sites, as these had follow-up data for both S. haematobium and
S.mansoni from all three years. We constructed a binomial GLMM, with S. haematobium or S.
mansoni infection status as the response, and school and child ID included as random intercept
terms. Fixed effects for baseline co-infection status (as a 3 or 4-level factor, depending on the
species), year (as a 3-level factor: baseline, first and second follow-up) and their interaction
term were used to examine whether temporal changes in infection for each species differed
according to initial co-infection status. Region, gender and mean-centred age at baseline (linear
and quadratic term) were fitted as covariates. Only children monitored at all three time-points
(baseline, first and second follow-up years) were included, such that we analysed changes in
infection probability over time in the same set of individuals. To examine whether drop-out
from the Malian cohort might be biased according to children’s infection status at baseline, we
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used a binomial mixed model to test which baseline variables predicted whether children had
full follow-up data. School was fitted as a random intercept term, alongside S. haematobium
and S.mansoni infection categories, with region, gender and mean-centred age at baseline (lin-
ear and quadratic term) as covariates.
In Senegal and Niger it was also possible to separate effects of co-infection on parasite clear-
ance from those on re-infection (the latter potentially including recommencement of egg-shed-
ding by uncleared worms), since individuals were monitored six weeks after PZQ treatment.
For each schistosome species, we used a binomial GLM with a logit link to test whether, among
individuals infected at baseline but clear of infection 6 weeks later (after PZQ treatment), the
probability of being re-infected 6 months from baseline depended on baseline co-infection sta-
tus (single vs. co-infected). Covariates included were village, baseline intensity category for the
focal species (2-level factor for S. haematobium: light vs. heavy; 3-level factor for S.mansoni:
light, moderate or heavy), gender and mean-centred age (as a linear and quadratic term). An
interaction term between village and co-infection status was also included to test for geographic
heterogeneity in the influence of co-infection. Among the same individuals, we also used nega-
tive binomial GLMs (using the glm.nb function in theMASS package) to examine whether the
intensity of re-infection at six months (eggs/gram stool for S.mansoni, or eggs/10ml urine for
S. haematobium) was dependent on co-infection status at baseline, including the same covari-
ates used in the binomial re-infection models.
Ethics statement
Full details on ethical approval granted are provided in the original publications from which
these data were gathered. In brief, ethical approval was obtained from the St Mary’s Hospital
Local Ethics Research Committee, R&D office (part of the Imperial College, London Research
Ethics Committee (ICREC; EC NO: 03.36. R&D No: 03/SB/033E) in combination with the
ongoing CONTRAST and SCI activities. Within Niger, Senegal and Mali, all aspects of sample
collections were carried out in the framework of the disease control activities implemented and
approved by the Ministry of Health (MOH) and adopted by regional and local administrative
and health authorities. In Senegal and Niger, the communities of the selected villages were
informed about the objectives, the methodology of the study and the advantages. A meeting
was organized with the population and verbal community consent was obtained for each
selected village. Written and verbal consent was also obtained from school directors and teach-
ers, as well as the children’s parents, prior to the recruitment of the children. Verbal assent was
given by every child and their acceptance documented. Participation was voluntary and chil-
dren could withdraw or be withdrawn from the study at any time without obligation. Results of
the different diagnostic procedures performed on children were briefly explained to them. In
Senegal and Niger, all children diagnosed as infected with schistosomiasis were immediately
treated with 40mg/kg. In Mali, all children at participating schools were treated shortly after
each survey, as part of the national schistosomiasis control programme activities.
Results
Baseline associations between S. haematobium and S.mansoni
At baseline, associations between the two schistosome species were generally positive, although
varied in strength across countries and regions. In Mali, infection probability for both schisto-
some species was positively predicted by the level of infection with the other species, after con-
trolling for age and gender effects (Table 2). This relationship varied in strength across
geographical regions (S. haematobium: S.mansoniregion interaction χ26 = 22.28, p = 0.001; S.
mansoni: S. haematobiumregion interaction: χ24 = 12.63, p = 0.013, Fig 2). Among infected
Epidemiology of Schistosome Interactions
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Table 2. Baseline predictors of (A) S. haematobium and (B) S.mansoni infection probability across 29 co-endemic schools in Mali (n = 2477 chil-
dren). Parameter estimates (on the logit scale) are from binomial mixed models. χ2 and p values are from likelihood ratio tests comparing models with and
without the term in question. Age was mean-centred in both analyses. ‘ref’ indicates the reference level of each factor.
Variable df Parameter estimate (SE) χ2 p
(A) S. haematobium
(Intercept) 0.016 (0.360)
Age 1 0.105 (0.024) 18.760 <0.0001
Age2 1 -0.010 (0.012) 0.766 0.3816
Sex 1 Male (ref) 0 2.363 0.1243
Female -0.162 (0.105)
S. mansoni infection 3 Uninfected (ref) 0 51.066 <0.0001
Light 0.914 (0.207)
Moderate 1.411 (0.276)
Heavy 1.940 (0.306)
Region 2 Bamako (ref) 0 19.015 <0.0001
Koulikoro -0.894 (0.759)
Ségou 2.345 (0.545)
(B) S. mansoni
(Intercept) -3.391 (0.562)
Age 1 0.161 (0.035) 21.817 <0.0001
Age2 1 0.006 (0.017) 0.123 0.7253
Sex 1 Male (ref) 0 2.808 0.0938
Female -0.255 (0.149)
S. haematobium infection 2 Uninfected (ref) 0 56.630 <0.0001
Light 1.054 (0.202)
Heavy 1.861 (0.253)
Region 2 Bamako (ref(A) 0 13.499 0.0012
Koulikoro 4.441 (1.118)
Ségou 0.127 (0.807)
doi:10.1371/journal.pntd.0004019.t002
Fig 2. Baseline differences in infection probability for (A) S. haematobium and (B) S.mansoni among Malian children according to intensity of co-
infection. Raw data are plotted with 95% exact confidence intervals, which account for clustering of prevalence data by school. Patterns are plotted
separately for each of the three regions surveyed in Mali.
doi:10.1371/journal.pntd.0004019.g002
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individuals, infection intensity increased with the intensity of co-infection for both schistosome
species, although again the strength of this relationship varied across countries and regions
(Table 3; Fig 3). Across the 29 schools in Mali, these positive relationships for both S. haemato-
bium and S.mansoni infection intensity were usually observed within each school, with few
exceptions (Fig A in S1 Text).
Co-infection and the impact of PZQ
In both Senegal and Niger, egg reduction rates 6 weeks after the first PZQ dose did not differ sig-
nificantly according to co-infection status, for either S. haematobium or S.mansoni (Table 4).
Thus, there was no evidence that co-infection altered the efficacy of double dose PZQ.
Raw cure rates for each village and schistosome species according to co-infection status are
shown in Fig 4. For S. haematobium, CR was high (>90%) in Niger and showed no clear asso-
ciation with co-infection status. In Senegal, CR for S. haematobium was lower, particularly in
Nder (where all individuals were co-infected with S.mansoni) as well as in co-infected individ-
uals in Temeye (Fig 4A, Table 5). In a model including data from all four villages in Senegal
and Niger, co-infection did not significantly explain variation in S. haematobium clearance,
when controlling for significant effects of village and initial S. haematobium infection intensity
(Table 5A). In Temeye, co-infected children had a lower CR than those with single infections
(Fig 4A). However, models showed that this effect was equally well explained by higher S. hae-
matobium infection intensity as by co-infection. Considering data on parasitological cure from
Temeye only, both co-infection status and initial intensity had equal explanatory power in uni-
variate models (likelihood ratio tests for co-infection: χ21 = 4.16, p = 0.041; log(eggs per 10ml):
χ21 = 4.15, p = 0.042). However, neither term added significant explanatory power when the
other was already present in the model (likelihood ratio test for co-infection: χ2 = 1.74,
p = 0.187; log(eggs per 10ml): χ2 = 1.74, p = 0.188), suggesting that these two variables strongly
confound one another in Temeye.
For S.mansoni, CR was lower in Niger than in Senegal, though in neither country did CR
depend strongly on co-infection status (Fig 4B). In a model including data from all four vil-
lages, co-infection did not significantly explain S.mansoni clearance probability, when control-
ling for other effects, particularly strong variation between the two countries (Table 5B).
Among those who did not clear S.mansoni entirely, the number of remaining eggs was also not
predicted by S. haematobium co-infection (GLM on logged egg counts: co-infection term χ2 =
2.47, p = 0.116). In a model where clearance of all schistosome eggs of both species six weeks
after PZQ was the response, there was marginal evidence that co-infected individuals were less
likely to clear all parasites than those with single species infections, when controlling for differ-
ences in clearance rates between villages (Table 5C).
S. haematobium longitudinal infection dynamics
Patterns of S. haematobium infection post-treatment varied widely across sites. In Senegal,
rapid re-infection with S. haematobium was seen in Temeye, though not in Nder (Fig 5A and
5B), whereas in both Nigerien villages S. haematobium re-infection was much slower (Fig 5C
and 5D). In Mali, S. haematobium infection probability was higher in S.mansoni infected chil-
dren at baseline, and declined less rapidly, though by the second annual follow-up, no differ-
ences in prevalence were apparent according to baseline S.mansoni status (Fig 6A; Table A in
S1 Text). At the first annual follow-up (F1), an individual’s S. haematobium infection probabil-
ity was predicted by their change in S.mansoni infection since baseline: while controlling for
baseline S. haematobium status (i.e. predisposition to the focal species), children persistently
infected with S.mansoni (at baseline and follow-up) were more likely to be infected by S.
Epidemiology of Schistosome Interactions
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haematobium than those that never had S.mansoni, while those that either lost or gained S.
mansoni since baseline had intermediate infection probabilities (S.mansoni change: χ23 =
12.06, p = 0.007, controlling for significant effects of age, gender and baseline S. haematobium
infection category; Fig B in S1 Text). Among the 2197 children recruited at the 20 schools
where both schistosome species were monitored for all three years, 475 (22%) were only sam-
pled at baseline, 466 (21%) were seen in two of the three years, and 1256 (57%) were followed-
up in all three years. The mean number of follow-ups was 1.36. Drop-out analysis showed that
the probability of children having full follow-up data (and therefore being included in these
longitudinal analyses) was not affected by baseline infection status for S. haematobium or S.
mansoni, but declined with age and differed across regions (Table B in S1 Text).
S. haematobium re-infection isolated from lack of clearance
No S. haematobium re-infection was observed after 6 months in Nigerien co-endemic villages,
so variation in S. haematobium re-infection was only examined in Senegal. Among individuals
Fig 3. Infection intensity at baseline of (A) S. haematobium and (B) S.mansoni according to co-infection status in threeWest African countries.
Arithmetic mean log-transformed egg counts are plotted for each species among infected children only, with 95% confidence intervals that account for
clustering of the data by school in Mali, and by village in Senegal and Niger.
doi:10.1371/journal.pntd.0004019.g003
Table 4. Egg reduction rate (ERR) and cure rate (CR) by species and individual co-infection status
among children in Niger and Senegal. p-values comparing ERRs in single and co-infected subsets of indi-
viduals were derived using permutation tests. Numbers of individuals involved in each calculation are shown
in brackets.
Egg reduction rate (ERR) Cure rate (CR)
Single Co-infected p (permutation test) Single Co-infected
S. haematobium
Niger 98.6% (34) 99.4% (104) 0.515 94.1% (34) 98.1% (104)
Senegal 98.5% (18) 97.6% (146) 0.657 83.3% (18) 44.4% (146)
S. mansoni
Niger 84.8% (79) 78.9% (104) 0.304 63.3% (79) 56.7% (104)
Senegal 99.3% (19) 98.5% (142) 0.576 57.9% (19) 44.4% (142)
doi:10.1371/journal.pntd.0004019.t004
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with S. haematobium at baseline that had cleared infection six weeks after PZQ treatment, six
month re-infection rates were 14% in Nder (where 100% children had S.mansoni at baseline),
and 98% in Temeye (96% in children co-infected with S.mansoni at baseline vs. 100% in chil-
dren singly infected). In a model including data from both villages, re-infection probability was
strongly predicted by village (higher in Temeye than Nder, χ21 = 133.71, p<0.001) and was also
higher in individuals with heavy compared to light S. haematobium infection at baseline (χ22 =
6.17, p = 0.0130). As expected given the limited variation in re-infection rates in Temeye (the
only village where co-infection showed some variation), no significant effect of baseline S.man-
soni co-infection on re-infection probability was detected while controlling for village and other
effects (χ21 = 1.27, p = 0.259). However, across both Senegalese villages, the intensity of S. hae-
matobium re-infection at six months post-treatment (which varied more widely, range 0–372
eggs/10ml), was significantly lower in those individuals co-infected by S.mansoni at baseline
(Table 6A, Fig 7A). The negative binomial model provided a good fit to re-infection intensity
data, with observed counts closely matching expected values (Fig C in S1 Text) and a low over-
dispersion parameter (α = 1.2). It was not possible to test for an interaction between co-infection
status and village, as all individuals in Nder were co-infected at baseline. However, when limit-
ing the analysis to the village of Temeye, the same negative effect of S.mansoni co-infection on
S. haematobium re-infection intensity was seen (χ2 = 12.02, p = 0.0005). To explore this effect
further, we tested how the change in an individual’s S.mansoni infection status between base-
line, 6 weeks and 6 months predicted re-infection intensity, using data from both villages. This
showed that the major difference in S. haematobium re-infection intensity was between those
individuals that were S.mansoni negative at baseline but gained infection by 6 months (pattern
0-0-1), compared to those that were cleared of their original S.mansoni infection (1-0-0 and 1-
0-1; Table C in S1 Text). We also examined geographical variation in S. haematobium re-infec-
tion rates across all of the seven villages in Senegal and Niger assessed in our previous studies [4,
5]. We noted that village-level S. haematobium re-infection rate at six months tended to
decrease with increasing baseline mean S.mansoni infection intensity (Fig 7B).
Fig 4. Parasitological cure rates for (A) S. haematobium and (B) S.mansoniwith respect to co-infection status, in four co-endemic villages in
Senegal (red/pink) and in Niger (blue). Raw data are plotted with exact 95% confidence intervals.
doi:10.1371/journal.pntd.0004019.g004
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S.mansoni longitudinal patterns
Similar to S. haematobium, re-infection for S.mansoni was much quicker in Senegalese than
Nigerien villages (Fig 8). In Mali, S.mansoni prevalence declined over two annual PZQ treat-
ments, and this pattern differed only a minor amount according to baseline S.mansoni infec-
tion status (Table B in S1 Text): S.mansoni infection probability was higher in S. haematobium
positive children at baseline and declined less rapidly, though no differences according to base-
line S. haematobium infection status were visible after two years (Fig 7B). After one year, simi-
lar to the pattern seen for S. haematobium, S.mansoni infection probability was weakly
predicted by changes in S. haematobium infection: children persistently infected with S. hae-
matobium (at both baseline and first follow-up) were more likely to be infected with S.mansoni
than those that never had S. haematobium, with those that either lost or gained S. haemato-
bium intermediate (S. haematobium change: χ23 = 10.22, p = 0.017, controlling for effects of
age, gender, region and baseline S.mansoni infection category; Fig B in S1 Text).
Table 5. Factors predicting the probability of parasitological cure for (A) S. haematobium, (B) S.man-
soni and (C) any schistosome infection, six weeks after PZQ treatment in Senegalese and Nigerien vil-
lages where both species are endemic. Parameter estimates (on the logit scale) are from binomial mixed
models. χ2 and p values are from likelihood ratio tests comparing full models with and without the term in
question. ‘ref’ indicates the reference level of each factor.
Variable df Parameter estimate (SE) χ2 p
(A) S. haematobium (n = 302)
(Intercept) 0.519 (0.075)
log(S. haematobium eggs/10ml) 1 -0.043 (0.014) 9.213 0.0024
S. mansoni infection 3 Uninfected (ref) 0 1.101 0.7767
Light -0.032 (0.064)
Moderate -0.038 (0.071)
Heavy 0.031 (0.093)
Village 3 Nder (ref) 0 84.901 <0.0001
Namarigoungou 0.543 (0.065)
Diambala 0.516 (0.062)
Temeye 0.244 (0.063)
(B) S. mansoni (n = 344)
(Intercept) 0.950 (0.110)
log(S. mansoni epg) 1 -0.016 (0.020) 0.675 0.4112
S. haematobium infection 2 Uninfected (ref) 0 3.000 0.2232
Light -0.040 (0.056)
Heavy -0.152 (0.089)
Village 3 Nder (ref) 0 31.351 <0.0001
Namarigoungou 0.250 (0.069)
Diambala -0.262 (0.068)
Temeye 0.121 (0.074)
(C) Both species combined (n = 399) (Intercept) -0.402 (0.314)
Infection status 1 One species (ref) 0 3.066 0.0799
Two species -0.411 (0.235)
Village 3 Nder (ref) 0 16.075 0.0011
Namarigoungou 0.964 (0.313)
Diambala 0.962 (0.313)
Temeye 1.159 (0.322)
doi:10.1371/journal.pntd.0004019.t005
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S.mansoni re-infection isolated from lack of clearance
In the four Senegalese and Nigerien villages, among children that had S.mansoni at baseline
but cleared it 6 weeks post-PZQ, re-infection probability at six months was strongly predicted
by village (χ23 = 65.73, p<0.0001), largely reflecting differences between the two countries (Fig
8). S. haematobium co-infection status did not predict S.mansoni re-infection probability (χ21
= 2.312, p = 0.128), while controlling for village, baseline S.mansoni infection intensity cate-
gory (χ22 = 0.799, p = 0.671), and age (Age
2 χ21 = 4.883, p = 0.027). These results reflect incon-
sistent patterns of re-infection rate according to S. haematobium co-infection status across the
four villages (single vs. co-infected in Temeye, Nder, Diambala and Namarigoungou: 100% vs.
88%, 67% vs. 97%, 33% vs. 38% and 92% vs. 59% respectively). In models of S.mansoni re-
infection intensity, again the strongest effect was village (Table 6B). However, a weak main
effect of S. haematobium co-infection on re-infection intensity was also detected while control-
ling for covariates, indicating slightly lighter S.mansoni re-infection overall among individuals
co-infected with S. haematobium at baseline (Table 6B). When an interaction term between
Fig 5. Longitudinal dynamics of S. haematobium in Senegal (A,B) and Niger (C,D), according to co-infection status with S.mansoni at baseline.
Means from raw data are plotted with 95% confidence intervals. Confidence intervals for prevalence are exact, and for intensity data were calculated using a
negative binomial GLM on egg counts including zero counts. Black and red lines indicate baseline single infections and co-infections with S.mansoni
respectively. Solid and dashed lines represent the villages of Temeye and Nder in A and B, and Diambala and Namarigoungou in C and D respectively.
There is no line for single infections in Nder because all infections in that village were co-infections.
doi:10.1371/journal.pntd.0004019.g005
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village and co-infection status was included in the model, however, this was also weakly signifi-
cant (χ23 = 7.943, p = 0.047), indicating that the effect of co-infection differed somewhat across
sites. This interaction term reflected a weak positive association between co-infection and S.
mansoni re-infection intensity in Nder and Diambala compared to a weak negative association
in Temeye and Namarigoungou (Fig D in S1 Text), though in single village analyses, the co-
infection term was always non-significant (all p>0.08). Overall therefore, S.mansoni re-infec-
tion was not strongly predicted by initial S. haematobium co-infection status, and the relatively
weak negative effect of co-infection on egg counts at six months was not consistent across sites.
We also checked whether any potential effect of S. haematobium co-infection on re-infection
intensity might depend on an individual’s initial S.mansoni infection intensity, but there was
no evidence for such an interaction (χ22 = 3.451, p = 0.178).
Discussion
Despite frequent co-endemicity of S. haematobium and S.mansoni across Africa, little is
known about the potential for within-host interactions between these two species, or whether
such interactions might affect the impact of PZQ treatment or host immunity. Here, we analyse
epidemiological data from school-age children in three West African countries (Senegal, Niger
and Mali), to explore whether these two species may interact with one another in the context of
PZQ treatment.
At baseline, associations between urogenital and intestinal schistosomiasis were generally
positive in all three countries: for both S. haematobium and S.mansoni, infection intensity
increased with the degree of co-infection, while controlling for other effects such as age, gender
and location, and in Mali children with one species were more likely to be infected by the
other, with some geographic variation in the strength of this association. Similar positive
Fig 6. Predicted changes in the probability of (A) S. haematobium and (B) S.mansoni infection, over successive rounds of treatment in the Malian
cohort according to co-infection status at baseline. Values shown are (cluster-specific) predicted values and standard errors from a binomial mixed
model, for a child of average age in the dataset. BL = baseline, F1 = first annual follow-up1, F2 = second annual follow-up.
doi:10.1371/journal.pntd.0004019.g006
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associations prior to treatment have been previously reported from other co-endemic villages
in Senegal [7], and Cameroon [38]. Such positive associations may be driven by a number of
processes, including correlated exposure of children to infective Bulinus and Biomphalaria
snails at the same transmission sites, correlated immune susceptibility of individuals to infec-
tion by the two species, and/or facilitative interspecific interactions within the host. Few studies
Table 6. Re-infection intensity 6-months after baseline among individuals that cleared their infection
6 weeks after PZQ treatment, modelled by negative binomial GLMs. Baseline infection intensity for the
focal species was retained in models even when not significant, so the effect of co-infection over and above
effects of the focal species could be assessed. χ2 and p values are from likelihood ratio tests comparing full
models with and without the term in question. Age was mean-centred in analyses. ‘ref’ indicates the reference
level of each factor.
Variable df Parameter estimate (SE) χ2 p
S. haematobium eggs/10ml (n = 70; Senegal
only)
(Intercept)
Baseline S. haematobium infection 1 Light (ref) 0 1.891 0.1691
Heavy 0.800 (0.556)
Sex 1 Male (ref) 0 0.013 0.9092
Female 0.051 (0.429)
Age 1 -0.189
(0.100)
4.322 0.0376
Age2 1 -0.041
(0.037)
1.15 0.2836
Village 1 Nder (ref) 0 50.374 <0.0001
Temeye 4.396 (0.720)
Baseline S. mansoni infection 1 Not infected
(ref)
0 10.713 0.0011
Co-infected -1.657
(0.498)
S. mansoni eggs/gram(n = 225, Senegal and
Niger)
(Intercept) 6.598 (0.393)
Baseline S. mansoni infection 2 Light (ref) 0 2.798 0.2469
Moderate 0.440 (0.249)
Heavy 0.092 (0.363)
Sex 1 Male (ref) 0 0.296 0.5866
Female 0.119 (0.220)
Age 1 -0.021
(0.042)
Age2 1 -0.039
(0.014)
6.818 0.0090
Village 3 Nder (ref) 0 78.815 <0.0001
Temeye -0.902
(0.322)
Diambala -3.608
(0.353)
Namarigoungou -2.255
(0.343)
Baseline S. haematobium infection 1 Not infected
(ref)
0 4.683 0.0305
Co-infected -0.602
(0.266)
doi:10.1371/journal.pntd.0004019.t006
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have examined the evidence for correlated exposure to S. haematobium and S.mansoni, and
while some have in fact suggested these species may have distinct local transmission sites
within villages [39, 40], further work is needed to examine the extent to which correlated expo-
sure, or other mechanisms, may drive the positive associations between schistosome species
documented here and elsewhere.
In analysing data from two efficacy studies with similar methodology in Senegal and Niger,
we found that the efficacy (ERR) of two (three week spaced) PZQ doses against either S. hae-
matobium or S.mansoni was not significantly altered by the presence of co-infection. This is
encouraging, though the effect of co-infection on efficacy still requires testing for the standard,
single 40mg/kg dose of PZQ widely used in control programmes. Parasitological cure rates told
a somewhat different story, with clearance probability for S. haematobium reduced in mixed
infections compared to single infections in Senegal, but not Niger. Further analysis showed
that this effect of S.mansoni on S. haematobium clearance disappeared once initial infection
intensity was controlled for, suggesting intensity differences likely underpinned reduced clear-
ance of S. haematobium from mixed infections in Senegal. While it is well known that heavy
infections are less likely to be cleared by a standard dose of PZQ [41–43], a key question arising
from our findings is to what extent S.mansoni co-infection causes, or is merely correlated with,
increased infection intensity for S. haematobium. The answer will determine whether co-
endemicity in an area per se is cause to consider higher or more repeated doses of PZQ to get
full infection clearance. Our finding of reduced overall clearance for S. haematobium/S.man-
soni co-infections compared to single infections agrees with a recent meta-analysis of studies
Fig 7. Relationship between S. haematobium re-infection 6months post-PZQ in Senegalese and Nigerien villages, and S. mansoni co-infection at
the point of treatment (baseline). (A) Negative association between S.mansoni co-infection and the intensity of S. haematobium re-infection from a
negative binomial GLM on Senegalese data (n = 70). Values are predicted values from the minimal model in Table 6A, for an individual of average age, living
in Temeye with a light S. haematobium infection prior to treatment. Errors bars represent 1 standard error. (B) Relationship between mean S.mansoni
infection intensity and the proportion of individuals re-infected with S. haematobium six months after PZQ treatment across seven villages in Niger (red dots)
and Senegal (black dots).
doi:10.1371/journal.pntd.0004019.g007
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using the standard 40mg/kg PZQ dose [44] in suggesting mixed infections may be harder to
clear. Again whether this observation is due to mixed infections simply being heavier, or other
effects remains unclear. Our results did not suggest a consistent difference in PZQ efficacy
against the two species: S.mansoni showed lower ERR and CR than S. haematobium in Niger
[4], though this was not seen in Senegal [5]. Another study with very similar methodology
reported higher ERR and CR for S.mansoni than S. haematobium in co-endemic sites in Cam-
eroon [45]. These mixed findings echo two recent studies synthesizing cure rate data for uro-
genital and intestinal schistosomiasis, which showed large geographic variability but only
limited species differences in PZQ-related clearance overall [43, 44]. We also show that even
after controlling for differences in initial infection intensity, co-infection status and other vari-
ables, large differences in cure rates were observed between Senegal and Niger for both urogen-
ital and intestinal schistosomiasis. Moreover, while S. haematobium ERR was similar in the
Senegalese and Nigerien villages, ERR for S.mansoni was notably lower in Niger. These geo-
graphic differences may reflect intraspecific genetic differences in schistosomes, as seen across
other West African countries [46], or geographic differences in the prevalence of cryptic hybrid
Fig 8. Longitudinal dynamics of S.mansoni in Senegal (A, B) and Niger (C, D), according to co-infection status at baseline.Means from raw data are
plotted with 95% confidence intervals. Confidence intervals for prevalence are exact, and for intensity data were calculated using a negative binomial GLM on
egg counts including zero counts. Black and red lines indicate baseline single infections and co-infections with S. haematobium respectively. Solid and
dashed lines represent the villages of Temeye and Nder in A and B, and Diambala and Namarigoungou in C and D respectively. There is no line for single
infections in Nder because all infections in that village were co-infections.
doi:10.1371/journal.pntd.0004019.g008
Epidemiology of Schistosome Interactions
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004019 October 15, 2015 18 / 25
schistosomes that may differ in susceptibility to PZQ [47], both possibilities warranting further
investigation.
Patterns of re-infection for both schistosome species varied markedly between countries,
and to a lesser extent among sites within each country. Variation in transmission site ecology,
for example changes in the abundance of Biomphalaria and Bulinus snails, as well as seasonal-
ity are likely to play important roles in driving these differences [48]. However, when control-
ling for geographic location, we revealed a somewhat counterintuitive effect of interspecific co-
infection on the degree of short-term re-infection (6 months after PZQ treatment). Since base-
line associations between S. haematobium and S.mansoni were generally positive, one might
expect to see higher levels of re-infection among individuals that were co-infected at baseline,
that would re-establish these positive associations post-treatment. However, we found the
opposite pattern in data from Senegal. Despite S.mansoni co-infected individuals having
higher S. haematobium egg counts at baseline, after effective treatment they had significantly
lower S. haematobium egg counts six months later than those with single infections at baseline.
This result could indicate some kind of asymmetric competitive interaction between S.man-
soni and S. haematobium, whereby S.mansoni infection at the point of treatment limits the
extent to which S. haematobium can re-infect or shed eggs after treatment. Although it was not
possible to test for the same individual-level effect in Niger (since no participants were re-
infected by S. haematobium at six months), we did observe at a population-level that the pro-
portion of individuals re-infected with S. haematobium in a given location was negatively
related to baseline mean intensity of S.mansoni infection. This pattern that is at least consistent
with the effect seen in Senegal, though may be influenced by other factors varying across sites,
such as environmental factors related to snail ecology. While there was some evidence for the
reverse pattern—S. haematobium co-infection at baseline limiting S.mansoni re-infection, the
effect was much weaker and geographically variable. Interestingly, a study with similar meth-
odology in Cameroon (conducted under the same multi-country CONTRAST project as the
Senegal and Niger studies reported here) also showed a reduced probability of S. haematobium
re-infection among children co-infected by S.mansoni at the time of PZQ treatment, though
the statistical significance of this difference was not tested [45]. Further studies are now needed
to test the generality of these patterns across a range of other co-endemic settings.
If these patterns do reflect asymmetric competition between S.mansoni and S. haemato-
bium after treatment, a range of possible mechanisms could be responsible. First, if baseline S.
mansoni co-infection is associated with faster or more intense S.mansoni re-infection, our
findings could arise though interspecific competition during re-infection. Such competition
could occur in the currency of mates, nutritional resources like blood (an important food
source for adult schistosomes) [49], or immune-mediated competition via cross-immunity to
cercariae, immature or adult worms. Mate competition between S.mansoni and S. haemato-
bium has been previously documented [14–16], and competitive asymmetry could arise if S.
mansonimales divert S. haematobium females away from their preferred ovipositing site more
often than the reverse pattern [16]. Competition for resources among schistosome species may
also affect patterns detected here, though to our knowledge resource-based competition among
schistosomes has not yet been explored. It also remains unclear to what extent S.mansoni and
S. haematobium elicit cross-protective immune responses in humans. The idea of heterologous
immunity in schistosomes has a long history, and there is clear evidence from animal models
that challenge by one species can sometimes protect against, or at least limit egg output from, a
challenge infection by another species [50]. Challenge experiments in hamsters have shown
that S.mansoni stimulates stronger cross protection than S. haematobium [20], and that S.
mansoni competes with S. haematobium at several stages, impairing worm development, sexual
maturation and egg shedding [22]. Moreover, a recent study conducted close to our study sites
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in Senegal [9] provided preliminary evidence for cross-immunity between these two species in
humans, as measured by serum cytokine production in response to egg or adult worm antigen.
Intriguingly, this study also showed that S.mansoni elicited somewhat stronger heterologous
responses than S. haematobium [9], consistent with our finding that S.mansoni was associated
with reduced S. haematobium re-infection, but not necessarily the other way around. Thus
cross-immunity between S.mansoni and S. haematobiummay well occur, and its importance
in humans warrants further investigation. To try and distinguish between mate, resource and
immune-mediated competition in our analyses, we tested whether the effect of baseline S.man-
soni status on S. haematobium re-infection varied according to subsequent S.mansoni clear-
ance or re-infection. Mate competition would be expected to show the strongest effect in
individuals that did not fully clear S.mansoni upon treatment, and cross-reactive immune
responses against re-infecting S.mansoni would predict the strongest effect in children who
were re-infected with S.mansoni six months later, compared to those with no patent infection.
In fact, we found that effect of baseline S.mansoni infection was similar regardless of whether
individuals were re-infected by S.mansoni six months after treatment, and was weakest in
those that did not clear S.mansoni in the first place. This suggests that the legacy of S.mansoni
infection, rather than active infection, is enough to generate competition with re-infecting S.
haematobium, which is possible if PZQ treatment exposes S.mansoni antigen that elicit heter-
ologous immunity. Indeed, PZQ treatment is known to alter immunity to schistosomes [51],
an effect that could extend to heterologous immunity. While we only examined school-age
children here, immunologically-driven patterns may differ depending on the length of expo-
sure to schistosomes. Therefore, studies involving adults would also be useful to further explore
the patterns reported here.
In apparent contrast to findings from Senegal, at co-endemic sentinel sites in Mali, the chil-
dren most likely to have S. haematobium at the first annual follow-up were those that main-
tained S.mansoni infection over the same period. Children maintaining S. haematobium were
also more likely to have S.mansoni at first follow-up. Despite appearing contradictory to find-
ings from the Senegalese and Nigerien villages (where negative associations between co-infec-
tion and re-infection were seen), such positive correlations in Mali may simply reflect a lack of
treatment in certain individuals: maintenance of infection with a given species could well indi-
cate that these children missed PZQ treatment in the national treatment campaign, and there-
fore would also be more likely to harbor the other schistosome species at follow-up. While data
from sentinel sites (where treatment coverage is imperfect), are less powerful than deliberate
treatment follow-up studies for examining potential interactions between schistosome species,
they can contribute to our understanding of how schistosome species composition is likely to
change as preventative chemotherapy programmes advance. In this respect, it is noteworthy
that in all three co-endemic West African countries examined here, among children that were
infected at baseline and had complete follow-up, over time the proportion of schistosome
infections attributable to S.mansoni as compared to S. haematobium, increased (Fig 9). A
whole range of processes may drive such population-level trends, including altered exposure
via changes in the relative abundance of Biomphalaria and Bulinus snails, or the re-infection
effect we observed in Senegal, whereby S.mansoni infection appeared to limit S. haematobium
re-infection after treatment. Whatever the underlying causes, it will be useful to study whether
an increase in the contribution of S.mansoni to infections post-treatment is a general pattern
beyond the three countries examined here.
In conclusion, our multi-country analysis of associations between S. haematobium and S.
mansoni throughout the process of PZQ treatment and re-infection provided no evidence for
altered efficacy of double-dose PZQ in co-infections compared to single infections, though co-
infections were sometimes heavier and less likely to clear completely after treatment. We also
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show that while controlling for other effects, children co-infected with S.mansoni in Senegal
showed reduced S. haematobium re-infection compared to singly infected children, which we
suggest may be driven by treatment-induced antigen exposure and stimulation of cross-protec-
tive immune responses. Furthermore, although the temporal dynamics of prevalence and
intensity for these two species were most strongly affected by location, suggesting local envi-
ronmental factors are the dominant drivers of re-infection patterns, in all three co-endemic
countries examined the proportion of infections attributable to S.mansoni relative to S. haema-
tobium increased over time post-treatment. Studies in other co-endemic areas are warranted to
test the generality of these findings, which have implications for our understanding of basic
schistosome biology, as well as relevance for schistosomiasis control as we move towards elimi-
nation in mixed species settings.
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